Assessing the Efficacy and Safety of the Allurion® Gastric Balloon in Latin American Patients: A Multicenter Case Series
Journal of Laparoendoscopic & Advanced Surgical Techniques · 2025
DOI: 10.1177/10926429251363490 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Laparoendoscopic & Advanced Surgical Techniques, 2025. Verfasst von María Emilia Muriel und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of bariatric and metabolic surgery, Sanatorio Allende, Av. Pedro Simón Laplace 5749, Córdoba, Argentina. Hauptthemen laut MEDLINE: Gastric Balloon, Obesity, Morbid. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Introduction
The Allurion® gastric balloon (AGB) is an innovative option for treating overweight individuals and those with grade I obesity, or as a bridging treatment for bariatric surgery, or for patients who do not desire surgical intervention. This study aimed to evaluate the efficacy and safety of the AGB in a multicentric cohort. Materials and Methods: A retrospective analysis of consecutive cases treated with AGB (≥18 years old with body mass index [BMI] ≥27) was performed in eight centers in three countries in Latin America (Argentina, Chile, and Perú), between September 2021 and September 2022, with a 12-month follow-up.
Results
In total, 402 patients were included (median BMI of 32.81 kg/m 2 ). Mean total weight loss percentage was 8.3%, 11.6%, and 14.9% at 3, 6, and 12 months, respectively, with a follow-up of 93.03%, 75.37%, and 40.54%. The adverse event rate was 1.24% ( n = 5). During the first 7 days, 34.58% ( n = 139) experienced concomitant symptoms, and 1.99% ( n = 8) asked for endoscopic balloon extraction because of intolerance. The complication rate was 6.46% ( n = 26). Readmission index was 4.97% ( n = 20), and reintervention was 2.23% ( n = 9). Balloon elimination was experienced by 5.7% of patients in the first 14 days, 29.10% ( n = 117) before the third month, and 62.68% ( n = 252) after the 16th week. Early deflation rate was 2.73% ( n = 11). Digestive track elimination was perceived by 26.61%.
Conclusions
AGB is a safe and effective option for the treatment of overweight and obesity in Latin America. Lifestyle changes and continuous support with a multidisciplinary team are essential to achieving good mid- to long-term outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of bariatric and metabolic surgery, Sanatorio Allende, Av. Pedro Simón Laplace 5749, Córdoba, Argentina.
- Investigation Department, Hospital César Milstein, Buenos Aires, Argentina.
- Department of bariatric and metabolic surgery, Diagnomed, Buenos Aires, Argentina.
- Department of bariatric and metabolic surgery, Centro Integral para el Tratamiento de la Obesidad y Sobrepeso, Paraná, Argentina.
- Department of bariatric and metabolic surgery, Centro médico NOVAMED, Región Metropolitana, Santiago de Chile, Chile.
- Department of bariatric and metabolic surgery, Sanatorio Británico, Rosario, Argentina.
ORCID-Profile: Manuel García, Mariano Palermo, Matías Sepulveda, Carlos Martín Esquivel
Zitieren
APA
Muriel, M. E., García, M., Martínez Lascano, F., Martínez, P. N., Caruso, D., Palermo, M., Piatanesi, M. P., Sosa, M., Castellaro, P. J., Sepulveda, M., Awruch, D., Tioni, R., Argonz, J. E., Puentes, M. E., Ferraro, A., Gancedo, M. C., Poggi Garland, L., Sibila Portmann Baracco, A., & Esquivel, C. M. (2025). Assessing the Efficacy and Safety of the Allurion® Gastric Balloon in Latin American Patients: A Multicenter Case Series. Journal of Laparoendoscopic & Advanced Surgical Techniques. https://doi.org/10.1177/10926429251363490
Vancouver
Muriel ME, García M, Martínez Lascano F, Martínez PN, Caruso D, Palermo M, et al. Assessing the Efficacy and Safety of the Allurion® Gastric Balloon in Latin American Patients: A Multicenter Case Series. Journal of Laparoendoscopic & Advanced Surgical Techniques. 2025. doi:10.1177/10926429251363490
BibTeX
@article{Muriel2025,
author = {Muriel, María Emilia and García, Manuel and Martínez Lascano, Fernando and Martínez, Pablo Nicolás and Caruso, Diego and Palermo, Mariano and Piatanesi, María de la Paz and Sosa, Matías and Castellaro, Pablo Javier and Sepulveda, Matías and Awruch, Diego and Tioni, Rogelio and Argonz, Julio Ernesto and Puentes, Maria Eleonora and Ferraro, Ariel and Gancedo, María Clotilde and Poggi Garland, Luciano and Sibila Portmann Baracco, Arianna and Esquivel, Carlos Martín},
title = {Assessing the Efficacy and Safety of the Allurion® Gastric Balloon in Latin American Patients: A Multicenter Case Series},
journal = {Journal of Laparoendoscopic & Advanced Surgical Techniques},
year = {2025},
doi = {10.1177/10926429251363490}
}
EUVIMED